News & Events

News, industry insights and noteworthy events.

At Tanner, we take pride in the success of our partnerships and acknowledge the milestones achieved in pursuing our mission; to improve lives by increasing access to medicines around the world.

For media or press inquiries, please email us.

Contact Us

All Articles

  1. Tanner Pharma Group Signs a Distribution Agreement for Partner Therapeutics’ Product, Leukine®

    For Immediate Release Contact: Lindsey Stevens Tanner Pharma Group 704-552-8407 lstevens@tannerpharma.com CHARLOTTE, N.C. – Tanner Pharma Group, a global provider of integrated specialty access solutions, has announced the signing of a distribution agreement with Partner Therapeutics, Inc. (PTx), an integrated biopharmaceutical company. The agreement names Tanner Pharma Group as a distributor of Leukine® (sargramostim) in…

    Read More

  2. Tanner Pharma Group to Attend Pharmagora, PQMD, CPhI, US GCSG, and Asembia Conferences

    For Immediate Release Contact: Lindsey Stevens Tanner Pharma Group 704-552-8407 lstevens@tannerpharma.com CHARLOTTE, N.C. – Key directors from Tanner Pharma Group (“Tanner Pharma”), a Charlotte-based global pharmaceutical services company, will attend several healthcare conferences throughout the upcoming month of April. The team will join other global executives for the following events:  Pharmagora | April 7th…

    Read More

  3. Tanner Pharma Group To Attend Upcoming CPHI Worldwide Conference

    For Immediate Release Contact: Lindsey Stevens Tanner Pharma Group 704-552-8407 lstevens@tannerpharma.com CHARLOTTE, N.C. – Top executives from Tanner Pharma Group (“Tanner Pharma”), a Charlotte-based global pharmaceutical services company, will attend the CPhI Worldwide event on October 24 – 26 in Messe Frankfurt, Germany. Tanner Pharma leverages more than 15 years of pharma services experience to…

    Read More

  4. The Max Foundation and Tanner Pharma Partner on Innovative Drug Distribution Model

    For Immediate Release Contact: Lindsey Stevens Tanner Pharma Group 704-552-8407 lstevens@tannerpharma.com Seattle, W.A. – The Max Foundation, an international non-governmental organization dedicated to increasing global access to treatment, care, and support for people living with cancer, and Tanner Pharma Group, a global pharma services company that specializes in patient access to critical medication, have partnered…

    Read More

  5. Proveca and Tanner Pharma initiate global Managed Access Program for Sialanar®

    For Immediate Release Contact: Lindsey Stevens Tanner Pharma Group 704-552-8407 lstevens@tannerpharma.com CHARLOTTE, N.C. – Tanner Pharma Group’s Managed Access Programs (MAP) division and Proveca have agreed to launch a Managed Access Program for an oral formulation of glycopyrronium (Sialanar®) outside Europe and the USA. Sialanar is for the treatment of sialorrhea, or chronic drooling, in…

    Read More

  6. Hiring of Jonathan Bracey as Managing Director – UK

    For Immediate Release Contact: Joshua Cooper Tanner Pharma Group 704.552.8408 jcooper@tannerpharma.com CHARLOTTE, N.C., December 1, 2015 – Tanner Pharma Group is pleased to announce the hiring of Jonathan Bracey as Managing Director – UK, effective 1 December, 2015. Mr. Bracey brings two decades of management experience, making him an optimal candidate in leading the recently…

    Read More

  7. Tanner Pharma Group to Present at Bourne Partners 5th Annual Global Healthcare Executive Summit

    Joshua Cooper to Moderate Healthcare Services Panel, “Changing Dynamics of Pharma Services”   CHARLOTTE, N.C., August 21, 2015 – Tanner Pharma Group will be largely showcased at the upcoming Bourne Partners Fifth Annual Global Healthcare Executive Summit on September 3, in Charlotte, North Carolina. The conference, held at the internationally renowned Mint Museum, will feature…

    Read More

  8. Max Global Experience: Uganda

    Tanner Pharma Group is proud to serve as the title sponsor for The Max Foundation’s “Max Global Experience: Uganda,” an expedition to raise awareness and funds for increased cancer treatment access in Africa. In August, Banks Bourne, Founder & Chairman of Tanner Pharma Group / CEO of Bourne Partners, and Rob Keel, Director of TannerMAP,…

    Read More

  9. Tanner Pharma Group Executives to Present at 2015 BIO International

    Presentations to Focus on Enhancing Access and Commercial Success in Challenging International Markets with Minimal Risk and Investment CHARLOTTE, N.C. – Top executives from Tanner Pharma Group will speak at the largest life-science conference in the world, the 2015 BIO International Convention, scheduled for June 15-18 in Philadelphia. The presentations will provide key insights into…

    Read More

  10. Tanner Pharma Group Formed From Merger of Tanner Pharmaceuticals & BurnsAdler Pharmaceuticals

    New Firm’s Complementary Divisions Provide Single-Point Solutions for Clients Seeking Clinical Trial Sourcing, Global Access Programmes and Commercialization Expertise in Challenging Global Markets  CHARLOTTE, N.C. – Tanner Pharmaceuticals, Inc., a global pharma services company that provides access to pharmaceuticals through Global Access Programmes and Clinical Trials Sourcing, and BurnsAdler Pharmaceuticals, a specialty pharmaceutical company that licenses…

    Read More

Tanner Pharma Group uses cookies on its website. By continuing to access this website you are agreeing to Tanner Pharma Group’s Data Privacy Policy. For more information, click here.